Back to Homepage
Health

Japan Nobel Prize Winner Hopes Award Helps Advance Patient Care

Aglow News
October 8, 2025
Japan Nobel Prize Winner Hopes Award Helps Advance Patient Care

Japan Nobel Prize Winner Hopes Award Helps Advance Patient Care

Sakaguchi was jointly awarded the 2025 Nobel Prize in Medicine alongside American scientists Mary Brunkow and Fred Ramsdell. Shimon Sakaguchi, the Japanese immunologist who won this year’s Nobel Prize in medicine, said Monday he hoped the award would help further advance research and patient care.

“I sincerely hope that this award will serve as an opportunity for this field to develop further… in a direction where it can be applied in actual bedside and clinical settings,” Sakaguchi, a 74-year-old distinguished professor at Osaka University, told a news conference.

Article image

Sakaguchi was jointly awarded the 2025 Nobel Prize in Medicine alongside American scientists Mary Brunkow and Fred Ramsdell for their research into how the immune system is kept in check by identifying its “security guards”, the Nobel jury said. Their discoveries have been decisive for understanding how the immune system functions and why we do not all develop serious autoimmune diseases.

The trio’s work has paved the way for new treatments for autoimmune diseases, cancer, and organ transplant rejection.Sakaguchi explained that further studies of the human immune system, both enhancing and suppressing it, could lead to prevention methods and treatments for such diseases as cancer and rejection in organ transplant cases.“I believe that even for diseases that are currently difficult to treat, solutions exist, effective treatments will inevitably be found, and preventive measures will also be discovered,” he said. Sakaguchi added that the award was a pleasant surprise.

The trio will receive their prize — a diploma, a gold medal and $1.2 million split three ways — at a formal ceremony in Stockholm on December 10.

Tags

Health

Related Posts

Health: US To Zero Out Tariffs On UK Pharma Under Trade Deal

Health: US To Zero Out Tariffs On UK Pharma Under Trade Deal

The United States has agreed to eliminate tariffs on British pharmaceutical imports under a new deal requiring the UK to increase spending on American-made drugs by 25 percent. The agreement, announced Monday, aims to correct what US officials describe as long-standing trade imbalances and ensure fairer pricing for American treatments. In exchange for tariff relief, the UK’s NHS will pay higher prices for new US therapies, becoming the only country granted exemption from the steep tariffs introduced on October 1. The move comes amid broader US scrutiny of global drug-pricing practices and follows major investment commitments in US manufacturing by firms such as AstraZeneca and Pfizer.

NTS Urges FG To Prioritise Health Funding, Modernise Hospitals

NTS Urges FG To Prioritise Health Funding, Modernise Hospitals

The Nigerian Thoracic Society (NTS) has urged the Federal Government to prioritise increased health funding and modernise hospital infrastructure to address Nigeria’s rising burden of respiratory diseases. In a communiqué issued after its 32nd Annual General Meeting in Lagos, the society called for fully equipped regional centres of excellence, stronger documentation practices, and wider public education on tobacco risks and emergency response. Delegates also examined how technology and AI can enhance respiratory care, stressing that while AI offers major benefits, it cannot replace healthcare professionals.

Cervical Cancer Vaccine Push Has Saved 1.4 Million Lives — Gavi

Cervical Cancer Vaccine Push Has Saved 1.4 Million Lives — Gavi

Gavi, the Vaccine Alliance, says its three-year campaign to expand access to HPV vaccines in low-income countries has prevented an estimated 1.4 million future cervical cancer deaths. The organisation reports that 86 million girls are now protected against HPV—the leading cause of cervical cancer—which disproportionately affects poorer nations lacking screening and treatment services. HPV-related cervical cancer caused 350,000 deaths in 2022, with 90% occurring in low-income countries. Gavi added that vaccine coverage in Africa has risen from 4% in 2014 to 44% in 2024, supported by reduced vaccine prices and increased manufacturer commitments.

Share this article